Lipid Nanoparticles with a Solid Matrix (SLN®, NLC®, LDC®) for Oral Drug Delivery

Author： Muchow Marc Maincent Philippe Muller Rainer

ISSN： 0363-9045

Source： Drug Development and Industrial Pharmacy, Vol.34, Iss.12, 2008-12, pp. : 1394-1405

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Characterization Methods for Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC)

Current Pharmaceutical Design, Vol. 23, Iss. 43, 2018-02 ,pp. : 6630-6642

Bentham Science Publishers

Access to resources Recommend Favorite

Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art

By Muller R.H. Mader K. Gohla S.

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 50, Iss. 1, 2000-07 ,pp. : 161-177

Elsevier

Access to resources Recommend Favorite

Solid lipid nanoparticles (SLN) for controlled drug delivery - Drug release and release mechanism

By zur Muhlen A. Schwarz C. Mehnert W.

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 45, Iss. 2, 1998-03 ,pp. : 149-155

Elsevier

Access to resources Recommend Favorite

Editorial: Applications of Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC): State of the Art

Current Pharmaceutical Design, Vol. 23, Iss. 43, 2018-02 ,pp. : 6551-6552

Bentham Science Publishers

Access to resources Recommend Favorite

Skin Localization of Lipid Nanoparticles (SLN/NLC): Focusing the Influence of Formulation Parameters

Current Drug Delivery, Vol. 13, Iss. 7, 2016-10 ,pp. : 1100-1110

Bentham Science Publishers

Access to resources Recommend Favorite